Trials / Unknown
UnknownNCT05170165
A Pilot Study to Increase Utilization of GDMT in Patients With HFrEF
A Pilot Study to Increase Utilization of Guideline Directed Medical Therapy in Patients With HFrEF
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Cedars-Sinai Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test a clinical decision support (CDS) tool that provides clinicians (cardiologists and nurse practitioners) medication recommendations regarding guideline directed medical therapy (GDMT) in patients with heart failure and reduced ejection fraction (HFrEF).
Detailed description
The purpose of our study is to test whether home blood pressure monitoring (HBPM) with clinical-decision support (CDS) will optimize the use of GDMT in patients with HFrEF. HBPM allows cardiologists and NPs to monitor patients outside the clinical setting so that GDMT can be safely initiated and up-titrated. The CDS employs HBPM and electronic medical record (EMR) data to implement the ACC/AHA HF guidelines and provides cardiologists and NPs with GDMT recommendations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Using a clinical decision software to provide specific recommendation of a medication at a certain dosage | During routine follow-up, clinicians, cardiologists, and NPs who have a scheduled visit with an enrolled patient will be offered a medication recommendation. The medication recommendation will be generated by the clinical decision support tool. The software will advise the cardiologist whether an HF medication should be initiated, discontinued, or the dosage titrated and if the patient requires labs. In addition, the software, or decision engine (DE), will be run once weekly and every time the patient has new basic metabolic panel results. If the patient is admitted to the hospital, skilled nursing facility, or inpatient rehabilitation unit, the use of DE will be placed on hold until the patient is discharged and at home. |
Timeline
- Start date
- 2022-01-12
- Primary completion
- 2023-09-25
- Completion
- 2023-09-25
- First posted
- 2021-12-27
- Last updated
- 2023-09-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05170165. Inclusion in this directory is not an endorsement.